XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of fair value assets and liabilities measured on recurring basis
The following table presents the balances of financial assets and liabilities measured at fair value on a recurring basis at the dates indicated (dollars in thousands):
 
Fair Value Measurements at March 31, 2019 Using
 
Balance at March 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
Federal agencies and GSEs
$
130,972

 
$

 
$
130,972

 
$

Mortgage-backed and CMOs
108,477

 

 
108,477

 

State and municipal
77,970

 

 
77,970

 

Corporate
6,870

 

 
6,870

 

Total securities available for sale
$
324,289

 
$

 
$
324,289

 
$

Equity securities
$
2,069

 
$

 
$
2,069

 
$

Liabilities:
 
 
 
 
 
 
 
Derivative - cash flow hedges
$
1,529

 
$

 
$
1,529

 
$

 
Fair Value Measurements at December 31, 2018 Using
 
Balance at December 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
Federal agencies and GSEs
$
134,039

 
$

 
$
134,039

 
$

Mortgage-backed and CMOs
111,867

 

 
111,867

 

State and municipal
79,902

 

 
79,902

 

Corporate
6,845

 

 
6,845

 

Total securities available for sale
$
332,653

 
$

 
$
332,653

 
$

Equity securities
$
1,830

 
$

 
$
1,830

 
$

Liabilities:
 
 
 
 
 
 
 
Derivative - cash flow hedges
$
804

 
$

 
$
804

 
$

Schedule of assets that were measured at fair value on a nonrecurring basis
The following table summarizes the Company's assets that were measured at fair value on a nonrecurring basis at the dates indicated (dollars in thousands):
 
Fair Value Measurements at March 31, 2019 Using
 
Balance at March 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2019
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Loans held for sale
$
1,252

 
$

 
$
1,252

 
$

Impaired loans, net of valuation allowance
168

 

 

 
168

Other real estate owned, net
646

 

 

 
646

 
Fair Value Measurements at December 31, 2018 Using
 
Balance at December 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2018
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Loans held for sale
$
640

 
$

 
$
640

 
$

Impaired loans, net of valuation allowance
171

 

 

 
171

Other real estate owned, net
869

 

 

 
869

Schedule of quantitative information of assets measured at Level 3
Quantitative Information About Level 3 Fair Value Measurements as of March 31, 2019 and December 31, 2018:
Assets
 
Valuation Technique
 
Unobservable Input
 

Rate
 
 
 
 
 
 
 
Impaired loans
 
Discounted appraised value
 
Selling cost
 
8.00%
 
 
Discounted cash flow analysis
 
Market rate for borrower (discount rate)
 
3.25% - 9.80%
 
 
 
 
 
 
 
Other real estate owned, net
 
Discounted appraised value
 
Selling cost
 
8.00%
 
Schedule of carrying values and estimated fair values of the entity's financial instruments
The carrying values and the exit pricing concept fair values of the Company's financial instruments at March 31, 2019 are as follows (dollars in thousands):
 
Fair Value Measurements at March 31, 2019 Using
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 
Fair Value
 
Carrying Value
 
Level 1
 
Level 2
 
Level 3
 
Balance
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
70,861

 
$
70,861

 
$

 
$

 
$
70,861

Equity securities
2,069

 
 
 
2,069

 
 
 
2,069

Securities available for sale
324,289

 

 
324,289

 

 
324,289

Restricted stock
5,299

 

 
5,299

 

 
5,299

Loans held for sale
1,252

 

 
1,252

 

 
1,252

Loans, net of allowance
1,347,257

 

 

 
1,337,337

 
1,337,337

Bank owned life insurance
19,047

 

 
19,047

 

 
19,047

Accrued interest receivable
5,373

 

 
5,373

 

 
5,373

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 

 
 

 
 

 
 

 
 

Deposits
$
1,559,790

 
$

 
$
1,561,355

 
$

 
$
1,561,355

Repurchase agreements
35,945

 

 
35,945

 

 
35,945

Junior subordinated debt
27,953

 

 

 
23,307

 
23,307

Accrued interest payable
846

 

 
846

 

 
846

Derivative - cash flow hedges
1,529

 

 
1,529

 

 
1,529

The carrying values and the exit pricing concept fair values of the Company's financial instruments at December 31, 2018 are as follows (dollars in thousands):
 
Fair Value Measurements at December 31, 2018 Using
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 
Fair Value
 
Carrying Value
 
Level 1
 
Level 2
 
Level 3
 
Balance
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
64,255

 
$
64,255

 
$

 
$

 
$
64,255

Equity securities
1,830

 
 
 
1,830

 
 
 
1,830

Securities available for sale
332,653

 

 
332,653

 

 
332,653

Restricted stock
5,247

 

 
5,247

 

 
5,247

Loans held for sale
640

 

 
640

 

 
640

Loans, net of allowance
1,344,671

 

 

 
1,334,236

 
1,334,236

Bank owned life insurance
18,941

 

 
18,941

 

 
18,941

Accrued interest receivable
5,449

 

 
5,449

 

 
5,449

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 

 
 

 
 

 
 

 
 

Deposits
$
1,566,227

 
$

 
$
1,570,721

 
$

 
$
1,570,721

Repurchase agreements
35,243

 

 
35,243

 

 
35,243

Junior subordinated debt
27,927

 

 

 
22,577

 
22,577

Accrued interest payable
795

 

 
795

 

 
795

Derivative - cash flow hedges
804

 

 
804

 

 
804